DOD and HHS team up on $1.1B coronavirus therapeutics purchase

Published



The Department of Defense has turned its Operation Warp Speed coronavirus effort to therapeutics, announcing a $375 million purchase agreement Wednesday to buy Eli Lilly’s as-yet unproven antibody treatment.

The joint announcement with the Department of Health and Human Services, its Operation Warp Speed partner, turns the multibillion-dollar effort launched by President Trump at the White House in May toward antibody treatments.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.